Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes

Teng Zhang,1,* Qin Ding,2,* Mengmeng Liu,1 Yanning Song,1 Lvfeng Zhang,1 Na Liang,1 Xia Zhao,1 Qian Wang,1 Xueli Guo,1 Guangmei Yang,1 Hongwei Zhang,1 Wei Chen2 1The Affiliated Encephalopathy Hospital of Zhengzhou University, Zhumadian, People’s Republic of China; 2Nutritiona...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang T, Ding Q, Liu M, Song Y, Zhang L, Liang N, Zhao X, Wang Q, Guo X, Yang G, Zhang H, Chen W
Format: Article
Language:English
Published: Dove Medical Press 2025-08-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/breath-and-bottle-evaluating-pharmacotherapy-for-alcohol-use-disorder--peer-reviewed-fulltext-article-COPD
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395710001152000
author Zhang T
Ding Q
Liu M
Song Y
Zhang L
Liang N
Zhao X
Wang Q
Guo X
Yang G
Zhang H
Chen W
author_facet Zhang T
Ding Q
Liu M
Song Y
Zhang L
Liang N
Zhao X
Wang Q
Guo X
Yang G
Zhang H
Chen W
author_sort Zhang T
collection DOAJ
description Teng Zhang,1,* Qin Ding,2,* Mengmeng Liu,1 Yanning Song,1 Lvfeng Zhang,1 Na Liang,1 Xia Zhao,1 Qian Wang,1 Xueli Guo,1 Guangmei Yang,1 Hongwei Zhang,1 Wei Chen2 1The Affiliated Encephalopathy Hospital of Zhengzhou University, Zhumadian, People’s Republic of China; 2Nutritional Department, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongwei Zhang, The Affiliated Encephalopathy Hospital of Zhengzhou University, Zhumadian, People’s Republic of China, Email hwzhang776@126.com Wei Chen, Nutritional Department, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China, Email cw13816728907@126.comBackground: The role of pharmacotherapy for alcohol use disorder (AUD) in mitigating COPD exacerbations remains underexplored. This study aims to evaluate the impact of AUD pharmacotherapy on COPD-related clinical outcomes.Methods: A retrospective cohort study was conducted on 635 COPD patients with comorbid AUD. Patients were categorized into two groups based on whether they received medication for AUD (MAUD group) or not (no-MAUD group). Data on demographics, COPD severity, exacerbation rates, and AUD treatment were extracted from electronic medical records.Results: Individuals in the MAUD group (n=229) exhibited a substantially reduced frequency of COPD exacerbations when compared to those in the non-MAUD group (n=406), with a significant difference observed (P< 0.001). Additionally, the MAUD group experienced a longer duration before the first exacerbation event (P< 0.001).Conclusion: Pharmacotherapy for AUD appears to have a protective effect against the occurrence of COPD exacerbations and improved clinical outcomes in patients with comorbid AUD. These findings suggest that AUD treatment should be considered as part of a comprehensive management strategy for COPD patients with AUD.Keywords: alcohol use disorder, chronic obstructive pulmonary disease, exacerbation, addiction treatment
format Article
id doaj-art-e025931b54c74e0384d2ed99300e1fb4
institution Kabale University
issn 1178-2005
language English
publishDate 2025-08-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj-art-e025931b54c74e0384d2ed99300e1fb42025-08-20T03:39:31ZengDove Medical PressInternational Journal of COPD1178-20052025-08-01Volume 20Issue 126972704105413Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation OutcomesZhang TDing Q0Liu MSong Y1Zhang L2Liang NZhao XWang QGuo XYang GZhang HChen W3shanghai pulmonary hospitalPharmaceutical DepartmentThe Second People's Hospital of Zhumadian CityNutritional Department, Shanghai Pulmonary Hospital, School of MedicineTeng Zhang,1,* Qin Ding,2,* Mengmeng Liu,1 Yanning Song,1 Lvfeng Zhang,1 Na Liang,1 Xia Zhao,1 Qian Wang,1 Xueli Guo,1 Guangmei Yang,1 Hongwei Zhang,1 Wei Chen2 1The Affiliated Encephalopathy Hospital of Zhengzhou University, Zhumadian, People’s Republic of China; 2Nutritional Department, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongwei Zhang, The Affiliated Encephalopathy Hospital of Zhengzhou University, Zhumadian, People’s Republic of China, Email hwzhang776@126.com Wei Chen, Nutritional Department, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China, Email cw13816728907@126.comBackground: The role of pharmacotherapy for alcohol use disorder (AUD) in mitigating COPD exacerbations remains underexplored. This study aims to evaluate the impact of AUD pharmacotherapy on COPD-related clinical outcomes.Methods: A retrospective cohort study was conducted on 635 COPD patients with comorbid AUD. Patients were categorized into two groups based on whether they received medication for AUD (MAUD group) or not (no-MAUD group). Data on demographics, COPD severity, exacerbation rates, and AUD treatment were extracted from electronic medical records.Results: Individuals in the MAUD group (n=229) exhibited a substantially reduced frequency of COPD exacerbations when compared to those in the non-MAUD group (n=406), with a significant difference observed (P< 0.001). Additionally, the MAUD group experienced a longer duration before the first exacerbation event (P< 0.001).Conclusion: Pharmacotherapy for AUD appears to have a protective effect against the occurrence of COPD exacerbations and improved clinical outcomes in patients with comorbid AUD. These findings suggest that AUD treatment should be considered as part of a comprehensive management strategy for COPD patients with AUD.Keywords: alcohol use disorder, chronic obstructive pulmonary disease, exacerbation, addiction treatmenthttps://www.dovepress.com/breath-and-bottle-evaluating-pharmacotherapy-for-alcohol-use-disorder--peer-reviewed-fulltext-article-COPDalcohol use disorderchronic obstructive pulmonary disease exacerbationaddiction treatmentpsychosomatic medicine
spellingShingle Zhang T
Ding Q
Liu M
Song Y
Zhang L
Liang N
Zhao X
Wang Q
Guo X
Yang G
Zhang H
Chen W
Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes
International Journal of COPD
alcohol use disorder
chronic obstructive pulmonary disease exacerbation
addiction treatment
psychosomatic medicine
title Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes
title_full Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes
title_fullStr Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes
title_full_unstemmed Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes
title_short Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes
title_sort breath and bottle evaluating pharmacotherapy for alcohol use disorder on copd exacerbation outcomes
topic alcohol use disorder
chronic obstructive pulmonary disease exacerbation
addiction treatment
psychosomatic medicine
url https://www.dovepress.com/breath-and-bottle-evaluating-pharmacotherapy-for-alcohol-use-disorder--peer-reviewed-fulltext-article-COPD
work_keys_str_mv AT zhangt breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT dingq breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT lium breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT songy breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT zhangl breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT liangn breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT zhaox breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT wangq breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT guox breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT yangg breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT zhangh breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes
AT chenw breathandbottleevaluatingpharmacotherapyforalcoholusedisorderoncopdexacerbationoutcomes